PFI (MCA): Modeling the Transport of Pharmaceutical Agents Across the Placental Barrier
- Institution
- Iowa State University, IA
- Principal investigator
- Nicole N Hashemi
- Funding
- $350K
- Duration
- 2023–2026
Moonbase score
Still being scored
Abstract
The broader impact/commercial potential of this Partnerships for Innovation – Mid Career Advancement (PFI-MCA) project lies in an innovative approach and platform technology – integrating 3D cell culture, sensing, and imaging. This system will further enable understanding of physiological processes and can be personalized for each expecting mother using their stem cells, leading to higher accuracy in testing for the transport rate of specific compounds and setting safe exposure levels. The successful completion of this project will lead to an economical and physiologically relevant tool that accommodates testing of a larger number of compounds, facilitates high-throughput screening and rapid data collection, and thus ensures market potential for this technology. The proposed project presents a paradigm shift from the approach currently used to study the transport of pharmaceutical drugs through the placental barrier and their effects on the developing placenta. This platform will replicate the physiological matrix mechanics, hemodynamics, and compound’s ability to permeate through the placental barrier, which will enable quantitative studies to be performed on a vast range of pharmaceuticals to understand their interactions, including transport through the vasculature, and translocation across the placental barrier to diffuse into the fetal blood stream. Furthermore, the system can ultimately be personalized for each expecting mother using their stem cells. This could lead to higher accuracy in testing the transport rate of certain compounds while reducing the cost and enabling real-time monitoring and rapid data collection. Collectively, the proposed technology enables the understanding of critical metabolic and inflammatory processes in the placenta, laying the foundation for its potential commercialization in the future. This project is jointly funded by the Partnerships for Innovation program and the Established Program to Stimulate Competitive Research (EPSCoR). This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
LOADING MOONBASE SCORE
Questions for Iowa State University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NSF · Iowa State UniversityNot yet scored
Bioionics: Probing Cellular Ionic Attributes Enabled by a Novel Soft Bio-Ionic Transistors
Reza Montazami · $480K · 2025–2026
- NSF · Iowa State University76
Collaborative Research: RUI: Topologically protected magnetic phases in Heusler alloys
Lin Zhou · $350K · 2025–2026
- NSF · Iowa State University70
Collaborative Research: SEALing the mold: systems analysis of the fungal response to cell wall damage
Steven D Harris · $474K · 2025–2028